NYT Covid Headlines 3 Jan 2021 - 29 Dec 2020

 

1. 

   India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other

   The approvals, which include a shot developed by Bharat Biotech, an Indian pharmaceutical company, begin a vast campaign to inoculate the hard-hit nation’s 1.3 billion people.

   By EMILY SCHMALL and SAMEER YASIR

   Jan. 3, 2021

2. 

   How Taiwan Plans to Stay (Mostly) Covid-Free

   The island’s success against the coronavirus has created a sinking feeling for many residents: How much longer can their good fortune last?

   By RAYMOND ZHONG

   Jan. 2, 2021

3. 

   Virus Numbers Are Surging. Why Is New York’s Vaccine Rollout Sluggish?

   With a new variant of the virus emerging elsewhere in the country, it’s crucial to vaccinate New Yorkers quickly. But so far, only about 88,000 have received the shots.

   By JOSEPH GOLDSTEIN

   Jan. 1, 2021
4. 1. Dec. 30, 20

   2. 

      How the Sinopharm Vaccine Works

      Using inactivated coronaviruses to train the immune system.

      By JONATHAN CORUM and CARL ZIMMER

      Dec. 30, 2020

   3. 

      How the Novavax Vaccine Works

      Using a coronavirus protein to train the immune system.

      By JONATHAN CORUM and CARL ZIMMER

      Dec. 30, 2020

   4. 

      China Approves Covid-19 Vaccine as It Moves to Inoculate Millions

      Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials. But crucial questions remained unanswered.

      By SUI-LEE WEE and AMY QIN

      阅读简体中文版閱讀繁體中文版

      Dec. 30, 2020

   5. 

      China Has All It Needs to Vaccinate Millions, Except Any Approved Vaccines

      Across the country, local governments plan to inoculate 50 million people against the coronavirus by early next year. But the vaccines have not officially been approved.

      By SUI-LEE WEE

      阅读简体中文版閱讀繁體中文版

      Dec. 29, 2020

https://www.nytimes.com/spotlight/coronavirus-vaccine?name=styln-coronavirus-live&region=